Photo of Vikram (Vik)  Khurana, MBBS, PhD

Vikram (Vik) Khurana, MBBS, PhD


Accepting New Patients


Vik Khurana is an attending neurologist at Massachusetts General Hospital and a Visiting Scientist at the Whitehead Institute for Biomedical Research at MIT.



Clinical Interests
  • Parkinson's disease
  • Ataxia/gait disorders
  • Atypical parkinsonism
  • Multiple System Atrophy
Medical Education
  • PhD, Harvard University
  • MBBS, University of Sydney School of Medicine
  • Residency, Brigham and Women's Hospital|Residency, Prince of Wales Hospital
  • Fellowship, Massachusetts General Hospital
Board Certifications
  • Neurology
  • Boston: Massachusetts General Hospital
Patient Gateway
Yes, learn more
Insurances Accepted
  • Aetna Health Inc.
  • Beech Street
  • Blue Cross Blue Shield - Blue Care 65
  • Blue Cross Blue Shield - Indemnity
  • Blue Cross Blue Shield - Managed Care
  • Blue Cross Blue Shield - Partners Plus
  • Centene/Celticare
  • Cigna (PAL #'s)
  • Fallon Community HealthCare
  • Great-West Healthcare (formally One Health Plan)
  • Harvard Pilgrim Health Plan - ACD
  • Harvard Pilgrim Health Plan - PBO
  • Health Care Value Management (HCVM)
  • Humana/Choice Care PPO
  • Medicaid
  • Medicare
  • Medicare - ACD
  • Neighborhood Health Plan - ACD
  • Neighborhood Health Plan - PBO
  • OSW - Maine
  • OSW - New Hampshire
  • OSW - Rhode Island
  • Private Health Care Systems (PHCS)
  • Railroad Medicare
  • Senior Whole Health
  • TriCare
  • Tufts Health Plan
  • Unicare
  • United Healthcare (non-HMO) - ACD
  • United Healthcare (non-HMO) - PBO
Patient Age Group

Edit Profile


Vik Khurana is on the faculty at Harvard Medical School and Massachusetts General Hospital, and a Visiting Scientist at the Whitehead Institute for Biomedical Research. His clinical and research interests relate to  neurodegenerative movement disorders, including Parkinson's disease, multiple system atrophy and the cerebellar ataxias. He is a medical graduate of the University of Sydney, Australia, and came to Boston as a Fulbright Scholar and Merck Company Foundation Fellow in 2001, obtaining his Ph.D. in neurobiology from Harvard University in 2006. He completed his residency in Neurology at Brigham and Women's and Massachusetts General Hospitals, and Fellowship training in Movement Disorders and Ataxia at Massachusetts General Hospital. His research efforts at the Whitehead Institute aim to develop novel therapies for neurodegenerative diseases by using diverse model systems including patient-derived stem cells. This work is supported by funding from the Howard Hughes Medical Institute and JPB Foundation, and a Clinician Scientist Development Award to Dr Khurana from the American Brain and Parkinson's Disease Foundations.

Edit Profile

Research & Publications

Research Summary
Vik Khurana is interested in the molecular mechanisms underlying nerve cell death in neurodegenerative parkinsonism, ataxias and dementia.  His interests include a disease called multiple system atrophy that can present with either parkinsonism or ataxia. The overarching goal of his research is to develop therapies tailored to individual patients. His research uses diverse model systems to understand these diseases and to test drugs and small molecules, from patient-derived human stem cells (induced pluripotent stem cells) to simpler systems including rodent neurons, fruit flies and yeast cells.

View my most recent publications at PubMed

    1. Chung CY*, Khurana V*, Auluck PK, Tardiff DF, Mazzulli JR, Soldner F, Baru V, Lou Y, Freyzon Y, Cho S, Mungenast AE, Muffat J, Mitalipova M, Pluth MD, Jui NT, Schule B, Lippard SJ, Tsai LH, Krainc D, Buchwald SL, Jaenisch R, Lindquist S. Identification and Rescue of a-Synuclein Toxicity in Parkinson Patient-Derived Neurons. Science. 2013 Nov 22; 342(6161):983-87 *Equal contribution.
    2. Khurana V, Merlo P, Duboff B, Fulga TA, Sharp KA, Campbell SD, Gotz J, Feany MB. A neuroprotective role for the DNA damage checkpoint in tauopathy. Aging Cell. 2012 Apr; 11(2):360-2.
    3. Soldner F, Lagani?re J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, Khurana V, Golbe LI, Myers RH, Lindquist S, Zhang L, Guschin D, Fong LK, Vu BJ, Meng X, Urnov FD, Rebar EJ, Gregory PD, Zhang HS, Jaenisch R. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell. 2011 Jul 22; 146(2):318-31.
    4. Khurana V, Elson-Schwab I, Fulga TA, Sharp KA, Loewen CA, Mulkearns E, Tyynela J, Scherzer CR, Feany MB. Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet. 2010 Jul; 6(7):e1001026.
    5. Khurana V, Lindquist S. Modelling neurodegeneration in Saccharomyces cerevisiae: why cook with baker's yeast? Nat Rev Neurosci. 2010 Jun; 11(6):436-49.
    6. Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB. TOR-mediated cell-cycle activation causes neurodegeneration in a Drosophila tauopathy model. Curr Biol. 2006 Feb 7; 16(3):230-41.

Edit Profile


Neurology Associates
15 Parkman Street
Boston MA, 02114-3117
Phone: 617-726-8639617-726-3216
Fax: 617-726-4101

Edit Profile

Back to Top